DA32 Life Science Tech Acquisition Corp.
NASDAQ: DALS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Steven Kafka
- Headquarters
- New York City, United States
- IPO year
- 2021
- Market cap
- $264.2M
Loading DALS…
Loading profile data…Frequently asked questions about DALS
What does DA32 Life Science Tech Acquisition Corp. (DALS) do?
Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies. The firm intends to pinpoint promisin...
Where does DALS trade?
DA32 Life Science Tech Acquisition Corp. (DALS) trades on the NASDAQ Capital Market.
What sector is DALS in?
DA32 Life Science Tech Acquisition Corp. (DALS) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of DA32 Life Science Tech Acquisition Corp.?
Steven Kafka is the chief executive officer of DA32 Life Science Tech Acquisition Corp. (DALS).
Where is DA32 Life Science Tech Acquisition Corp. headquartered?
DA32 Life Science Tech Acquisition Corp. is headquartered in United States.
Does DALS pay a dividend?
DA32 Life Science Tech Acquisition Corp. (DALS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DALS go public?
DA32 Life Science Tech Acquisition Corp. (DALS) completed its initial public offering in 2021.